Latest filing published 13 May 2014 for JUNIPER PHARMACEUTICALS INC, €14k.
Insider track record
No signal scores available.
Valerie Lynne Andrews: trading record in brief
Valerie Lynne Andrews discloses dealings in Juniper Pharmaceuticals Inc to SEC (Form 4). Between 15 May 2006 and 8 May 2014, the trades on record add up to 19 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 13 May 2014, the filings show a share grant worth €14k in Juniper Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Valerie Lynne Andrews
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,024 shares@ US$6.57$.01 Par Value Common StockSEC:0001181431-14-019304:1
- 11,215 shares@ US$3.44$.01 Par Value Common StockSEC:0001140361-11-025181:0
- 8,720 shares@ US$0.01$.01 Par Value Common StockSEC:0001140361-11-025181:1
- 28,037 shares@ US$0.01$0.01 Par Value Common StockSEC:0001140361-10-037487:0
- 7,692 shares@ US$1.03$0.01 Par Value Common StockSEC:0001209191-10-037432:0
- 1,000 shares@ US$2.32$.01 Par Value Common StockSEC:0001140361-07-022257:0
6 of 6 declarations